Top of page Skip navigation
  • REGISTRATION NOW OPEN

    Early Bird fees available until 25 August

  • SAVE THE DATE

    Join us in Cardiff on 29 and 30 November 2017

Confirmed speakers so far include:

  • Dr Crawford Brown, Senior Vice President R&D, Allergan Biologics
  • Dr Steve Chatfield, Chairman, Prokarium
  • Dr Nigel Darby, Executive Advisor, GE Healthcare Life Sciences
  • Professor Alan Dickson, Professor of Biotechnology, University of Manchester
  • Andy Evans, Head of Macclesfield Site, AstraZeneca UK
  • Dr Jim Faulkner, Head of Manufacturing, Autolus
  • Dr Markus Gershater, Chief Scientific Officer, Synthace
  • Dr Ryan Guest, Director of Cell Production and Co-founder, Cellular Therapeutics
  • Dr Oliver Hardick, Chief Executive Officer, Puridify
  • Bo Kara, Head Process Development, GlaxoSmithKline
  • Dr Peter Levison, Senior Marketing Director - Downstream Processing, Pall Life Sciences
  • Dr John Liddell, Senior Scientific Advisor, Centre for Process Innovation
  • Dr Damian Marshall, Head of Analytical Development, Cell and Gene Therapy Catapult
  • Ian McCubbin, Lead, Advanced Therapies Manufacturing Task Force       
  • Jo Pisani, Partner, PwC Strategy&
  • Dr Daniel Smith, Chief Scientific Officer, Cobra Biologics
  • Dr Kajsa Stridsberg-Friden, Senior Project Manager Downstream, GE Healthcare Life Sciences
  • Dr Mike Sullivan, Head of Advanced Therapies, Innovate UK
  • Dr Andy Topping, Chief Scientific Officer, FUJIFILM Diosynth Biotechnologies
  • Richard Turner, Head of Downstream Processing, MedImmune
  • Dr Stephen Ward, Chief Operating Officer, Cell and Gene Therapy Catapult and Chair, BIA Manufacturing Advisory Committee